In vitro effects of Saiboku-to on cytokine production from peripheral blood mononuclear cells of bronchial asthma patients

Clinical Drug Investigation

Volumn 17, Issue 6, 1999, Pages 461-466

  Tohda, Yuji ^a,c   Haraguchi, Ryuta ^a   Kubo, Hirokazu ^a   Nakahara, Hiroshi ^a   Fukuoka, Masahiro ^a   Nakajima, Shigenori ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; SAIBOKU TO;

ADULT; ARTICLE; ASTHMA; BLOOD CELL; CELL CULTURE; CELL SUSPENSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERBAL MEDICINE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST;

EID: 0032984948     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199917060-00006     Document Type: Article

References (25)

1. 1. National Asthma Education Program Expert Panel Report. Guidelines for the diagnosis and management of asthma. NIH Publication, No. 91-3042 U.S. Department of Health and Human Services, 1991
2. 2. Corrigan CJ, Kay AB. T cell and cosinophils in the pathogenesis of asthma. Immunol Today 1992; 13: 501-7
3. 3. Lenfant C. International Consensus Report on Diagnosis and Management of Asthma. Clin Exp Allergy 1992; 22 (S1): 1-72
4. 4. British Thoracic Society Guidelines on the management of asthma. Thorax 1993; 48: S1-S24
5. 5. Makino S. Guidelines for treating allergic diseases, [in Japanese]. Tokyo Life Science. Medica (Tokyo), 1993
6. 6. Kobayashi S, Fueki R, Noguchi H, et al. Study of the effects of long-term administration of Saiboku-to extracts to treat bronchial asthma [in Japanese]. J Med Pharm Soc Wakan-Yaku 1985; 2: 598-9
7. 7. Nagano H, Kobayashi S, Nakajima S, et al. Study of the effects of long-term administration of Saiboku-to extracts to treat bronchial asthma [in Japanese]. Kokyu 1988; 7: 76-87
8. 8. Okudaira H, Miyamoto A. The effects of Saiboku-to on steroid-dependent bronchial asthma. Kampo Immuno-Allergy 1989; 3: 175-81
9. 9. Egashira Y, Ushijtma M, Yasunaga S. The effects of long-term administration of Saiboku-to extracts to adult asthma. Kampo Immuno-Allergy 1989; 3: 167-74
10. 10. Yamazaki K, Ohkawa K, Nakajima S. The effect of Saiboku-to on β-receptors, Kampo Immuno-Allergy 1988; 2: 15-22
11. 11. Okamoto S, Tada S, Kimura I, et al. The effects of Saiboku-to on lymphocyte functions of guinea pig asthma models. Kampo Immuno-Allergy 1994; 8: 24-8
12. 12. Terashi Y, Yukawa T, Terashi K, et al. A study on the effect of Saiboku-to administration on the lymphocyte subsets. Kampo Immuno-Allergy 1994; 8: 132-41
13. 13. Tei M. Saiboku-to (1) [in Japanese]. Chin Med 1995; 19: 363-7
14. 14. Nishimoto T, Higasa K, Arai M. et al. The effects of using Saiboku-to and tranirast in combination to treat bronchial asthma [in Japanese]. Shinyaku Rinsho 1988; 37: 74-83
15. 15. Nakajima S, Tohda Y, Ohkawa K, et al. Effect of Saiboku-to(TJ-96) on bronchial asthma. Induction of glucocorticoid receptor, beta-adrenaline receptor, IgE-Fc epsilon receptor expression and its effect on experomental immediate and late asthmatic reaction. Ann N Y Acad Sci 1993; 685: 549-60
16. 16. Eda R, Takahashi K, Tada S, et al. The effects of Saiboku-to on the lymphokine productivity of intractable asthma patients. Kampo Immuno-Allergy 1990; 4: 104-14
17. 17. Noma TA. Comparative study of antigen-specific IL-2 reaction-system inhibitory actions of various allergy antagonists. Kampo Immuno-Allergy 1990; 4: 10-21
18. 18. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone L Definition according to profiles of lymphokines activities and secreted proteins. J Immunol 1986; 136: 2348-57
19. 19. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for IL-5 in mucosal biopsies from asthma. J Clin Invest 1991; 87: 1541-6
20. 20. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 304
21. 21. Paul WE, Ohara J. B cell stimulatory factor-I/interleukin 4. Annu Rev Immunol 1987; 5: 429-59
22. 22. Nakanishi, K. Cytokine that controls IgE production. Annual Review Immunity, Chugai Igakusha, Tokyo, 38-46, 1994
23. 23. Pene J, Rouset F, Chretien I, et al. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cell. The role of soluble CD23 antigen. Eur J Immunol 1988; 18: 928-35
24. 24. Takizawa H, Ito K. Interleukin 6 receptors in human bronchial epithelial cells [in Japanese]. Nippon Kyobu Shikkan Gakkaishi 1992; 30s: 77-81
25. 25. Tohda Y, Haraguchi R, Nakahara H, et al. The effects of Saiboku-to on the cytokine production from the peripheral blood mononuclear cells of bronchial asthma patients. Kampo Immuno-Allergy 1995; 9: 38-45